Blog

Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations of $142.4 billion and $35.72 billion, respectively. Marlborough, MA-based

GE Vernova Inc. GEV is benefiting from acquisitions, either buying or integrating other businesses to strengthen its overall operations. GEV is enhancing its core strengths in electrification and

For investors seeking momentum, FT Vest Buffered Allocation Defensive ETF BUFT is probably on the radar now. The fund just hit a 52-week high and is up 18.8% from its 52-week low price of $20.74 per

Defense stocks, particularly those with European exposure, fell sharply on Dec 15, 2025 (as reported by CNBC), after President Zelenskyy indicated that Ukraine is willing to forgo its long-term NATO

•  DigitalBridge Group, Inc. (DBRG) shares surged 9.6% on news that SoftBank Group Corp. will acquire the company in a roughly $4 billion deal.
• Ultragenyx Pharmaceutical Inc. (RARE) shares plunged

The S&P 500 Index is set for another year of double-digit gains, building on its strong 23.3% rally in 2024 and 24.2% in 2023. The index has gained 17.7% as of Dec. 29, 2025.From post-election

Myriad Genetics, Inc. MYGN is well-poised to grow in the coming quarters due to its impressive cadence of product launches. The company is also progressing well in its refreshed long-term strategy

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

How can you tell a good

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

The easiest, most reliable way

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

How can

Investors looking to buy stocks in 2026 should look beyond soaring artificial intelligence stocks at strong, underperforming S&P 500 companies with huge near-term and long-term upside.

AI stocks

The year 2025 began with post-election optimism and expectations of a strong first quarter. Instead, markets were hit by the rise of low-cost AI initiatives from China, the adverse impact on the

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income and long-term wealth creation can benefit from adding dividend-paying

Kyverna Therapeutics’ KYTX lead CAR T-cell therapy candidate, mivocabtagene autoleucel (“miv-cel”, formerly KYV-101), is being developed in a pivotal phase II study for stiff person syndrome (SPS)

Electric Vehicle (EV) giant Tesla’s TSLA Cybertruck plans have suffered a major setback after South Korean battery materials supplier L&F Co announced that its 4680 battery deal has been reduced to

Edison International EIX has been investing to strengthen its infrastructure, modernize the grid, and expand its renewable clean energy portfolio to deliver reliable, resilient energy to its growing

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales

Investors are closely monitoring the Federal Reserve, as on Tuesday afternoon, the Fed will release notes from its December meeting. This is likely to give clues about how the central bank is

In the final stretch of the year, investors often look for signs of the Santa Claus Rally, a seasonal pattern wherein stocks tend to rise in the period from Dec. 24 to Jan. 5.

This pattern has

The Cooper Companies, Inc.’s COO growth is fueled by CooperVision’s premium lens migration and MiSight’s myopia-management leadership, supported by CooperSurgical’s women’s health and fertility

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how consumers pay for care — and how medical device companies compete for

The solid-state battery race is heating up. Factorial Energy, a Massachusetts-based start-up, plans to go public in mid-2026. The listing will provide $100 million in capital to advance its battery

Exact Sciences Corporation EXAS is well-poised to grow in the coming quarters, courtesy of its continuous investment in R&D efforts. In addition, EXAS’ commercial capabilities are driving stronger